POLYNAUT
LIVE

Serial Number

88261248

Owner

Somanautix Limited

Attorney

Ben Natter

Filing Date

Jan 14, 2019

Add to watchlist:

No watchlists yet
View on USPTO

POLYNAUT Trademark

Serial Number: 88261248 • Registration: 5987728

POLYNAUT is a trademark filed by Somanautix Limited on January 14, 2019. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Somanautix Limited

Histon, Cambridge CB249NL , GB

Entity Type: 99

SOMASERVE LIMITED

PIONEER HOUSE, CHIVERS WAY
HISTON, CAMBRIDGE CB24 9NL , GB

Entity Type: 24

Trademark Details

Filing Date

January 14, 2019

Registration Date

February 18, 2020

Published for Opposition

December 3, 2019

Goods & Services

Pharmaceutical preparations for the treatment and prevention of infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric diseases and disorders; reagents, diagnostics and therapeutic preparations for medical and veterinary use in oncology; therapeutic preparations for use in treating cancer in medical and veterinary patients; targeted medical and veterinary preparations for use in oncology; medical and veterinary preparations for use in chemotherapy and immunotherapy for the treatment and prevention of infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric diseases and disorders; medical and veterinary preparations for the delivery of compounds to the brain for the treatment and prevention of infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric diseases and disorders; medical and veterinary preparations for crossing the blood-brain barrier for the treatment and prevention of infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric diseases and disorders; medical and veterinary preparations for delivering reagents, diagnostics and therapeutics across the blood-brain barrier for the treatment and prevention of infectious, autoimmune, viral, metabolic, musculoskeletal, cardiovascular, genitourinary, central nervous system, endocrinological, immunological, obstetrical, gynaecological, oncological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric diseases and disorders

Chemicals used in science; chemicals for encapsulating, microencapsulating and decapsulating other chemicals; chemicals for the protection, delivery, transport and triggered or controlled release of other chemicals; chemicals for encapsulating, microencapsulating and decapsulating biologically active ingredients including enzymes and cells; reagents and diagnostic preparations for scientific or medical research use, and clinical or medical laboratory use in oncology; targeted diagnostic preparations for scientific or medical research use, and clinical or medical laboratory use in oncology

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Feb 18, 2025 REM1
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 20, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 20, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 20, 2022 REAP
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Dec 30, 2020 ASGN
CORRECTION UNDER SECTION 7 - PROCESSED
May 6, 2020 COC.
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
May 5, 2020 EROP
POST REGISTRATION ACTION MAILED - SEC. 7
May 4, 2020 PRAM
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 27, 2020 APRE
TEAS SECTION 7 REQUEST RECEIVED
Mar 21, 2020 ES7R
TEAS SECTION 7 REQUEST RECEIVED
Mar 20, 2020 ES7R
REGISTERED-PRINCIPAL REGISTER
Feb 18, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 3, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 3, 2019 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 28, 2019 CNSA
EXAMINER'S AMENDMENT ENTERED
Oct 28, 2019 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Oct 28, 2019 GNEN
EXAMINERS AMENDMENT E-MAILED
Oct 28, 2019 GNEA
EXAMINERS AMENDMENT -WRITTEN
Oct 28, 2019 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 8, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 8, 2019 CRFA
ASSIGNED TO LIE
Oct 7, 2019 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 1, 2019 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 3, 2019 GNRN
NON-FINAL ACTION E-MAILED
Apr 3, 2019 GNRT
NON-FINAL ACTION WRITTEN
Apr 3, 2019 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2019 NWOS
NEW APPLICATION ENTERED
Jan 17, 2019 NWAP